4-163129043-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138386.3(NAF1):c.1339G>A(p.Val447Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000389 in 1,106,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138386.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAF1 | NM_138386.3 | c.1339G>A | p.Val447Ile | missense_variant | 8/8 | ENST00000274054.3 | NP_612395.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAF1 | ENST00000274054.3 | c.1339G>A | p.Val447Ile | missense_variant | 8/8 | 1 | NM_138386.3 | ENSP00000274054.2 | ||
NAF1 | ENST00000422287.6 | c.1034-1928G>A | intron_variant | 1 | ENSP00000408963.2 | |||||
NAF1 | ENST00000509434.5 | c.114+8156G>A | intron_variant | 3 | ENSP00000427518.1 |
Frequencies
GnomAD3 genomes AF: 0.0000599 AC: 4AN: 66792Hom.: 0 Cov.: 14
GnomAD3 exomes AF: 0.0000136 AC: 2AN: 147510Hom.: 0 AF XY: 0.0000125 AC XY: 1AN XY: 79694
GnomAD4 exome AF: 0.0000375 AC: 39AN: 1039316Hom.: 0 Cov.: 30 AF XY: 0.0000350 AC XY: 18AN XY: 513750
GnomAD4 genome AF: 0.0000599 AC: 4AN: 66792Hom.: 0 Cov.: 14 AF XY: 0.0000992 AC XY: 3AN XY: 30230
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 09, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with NAF1-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 447 of the NAF1 protein (p.Val447Ile). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at